Search For "zydus lifesciences"
Pinkathon partners with Zydus to drive breast cancer awareness; Returns to
Updated : 5 months, 3 weeks ago IST
Hyderabad (Telangana) [India], December 11: Pinkathon, India's biggest women's run, today announced the 6th edition of Pinkathon Hyderabad, joining hands with global innovation-led healthcare company Zydus Lifesciences Ltd. to strengthen breast cancer awareness in India. The press conference
Read More
Pinkathon partners with Zydus to drive breast cancer awareness; Returns to
Updated : 6 months, 1 week ago IST
Bengaluru (Karnataka) [India], November 19: Pinkathon, India's biggest women's run, has joined hands with global innovation-led healthcare company Zydus Lifesciences Ltd. in a purpose-driven partnership to strengthen breast cancer awareness in India. The upcoming 8th edition of the Bengaluru
Read More
Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2
Updated : 8 months ago IST
Pennington (New Jersey) [US] / Ahmedabad (Gujarat) [India], August 30: Zydus Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, today announced positive topline results from the pivotal EPICS-III Phase 2(b)/3 clinical trial. In
Read More
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus' U.S
Updated : 12 months ago IST
New Jersey [US]/ Ahmedabad (Gujarat) [India], June 3: Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as "Zydus) today announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to a
Read More
Zydus' Net Profit up by 23% in FY 25
Updated : 1 year ago IST
Ahmedabad (Gujarat) [India], May 20: Zydus Lifesciences Limited announced financial results for the quarter / year ended on March 31, 2025.
Read More
25 Years of Listing on NSE - Zydus Lifesciences Limited
Updated : 1 year ago IST
Mumbai (Maharashtra) [India], May 3: To commemorate the 25th year of the listing of Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.) on the National Stock Exchange of India (NSE), a bell ringing ceremony was organized at BKC, Mumbai on 2nd May 2025. On this occasion, senior
Read More
Zydus receives approval from the US drug authority to produce cholesterol-
Updated : 1 year, 1 month ago IST
Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Niacin Extended-Release Tablets.
Read More
Celebrating the Legacy of Excellence and Innovation, Zydus Takeda Healthca
Updated : 1 year, 4 months ago IST
Mumbai, Vashi (Maharashtra) [India], January 31: Zydus Takeda Healthcare Private Limited (ZTHPL), a joint venture company set up by Zydus Lifesciences Limited and Takeda Pharmaceutical Company Limited (Takeda) (TSE:4502/NYSE:TAK), celebrates the 25th anniversary of the Vashi manufacturing pl
Read More
"Honoured to receive this recognition and consider myself fortunate": Zydu
Updated : 1 year, 4 months ago IST
Chairman of Zydus Lifesciences, Pankaj Patel, on Sunday expressed his gratitude upon being bestowed with one of India's highest civilian honours and thanked the Government of India for the recognition as he humbly accepted the honour.
Read More
Zydus Reports 97 per cent Growth in Net Profit in FY24
Updated : 2 years ago IST
Ahmedabad (Gujarat) [India], May 18: Zydus Lifesciences Limited announces Q4 and FY24 financial performance. Summary:
Read More
Zydus Launches IBYRA, the Generic Version of Olaparib, Brings Both Access
Updated : 2 years, 2 months ago IST
Ahmedabad (Gujarat) [India], March 14: In a significant stride towards making advanced cancer treatment accessible to all, Zydus has launched Olaparib, a PARP inhibitor, under the brand name IBYRA in India. The drug will target specific genetic mutations prevalent in certain types of cancers
Read More
Zydus Lifesciences Launches Rexigo, the Oral Once-a-Day Pill for Advanced
Updated : 2 years, 4 months ago IST
Ahmedabad (Gujarat) [India], January 30: Zydus Lifesciences Ltd., a global innovation-driven healthcare company announced that it has launched Relugolix under the brand name, Rexigo™. This is the first and only oral once-a-day therapy for testosterone suppression in patients with advan
Read More